To provide a forum to discuss and advance statistical topics related to Research, Discovery (including efficacy models), Regulatory and Investigative Toxicology/Safety Assessment and to promote the involvement of Statisticians in these areas.
Our membership consists of statisticians at CROs, pharmaceutical companies and academia who are working in areas such as:
- Discovery
- Good statistical practice in in-vitro, ex-vivo and in-vivo assay development
- Reproducibility and Translation from pre-clinical to clinical
- Toxicogenomics
- Genetic Toxicology
- Acute Toxicology
- General Toxicology
- Eco-Toxicology
- Toxicokinetics
- DMPK / Pharmacokinetics
- ECG
- Immuno Toxicology
- Histopathology
- Pharmacology
- Developmental and Reproductive Toxicology
- Carcinogenicity
We discuss diverse topics ranging from Dog Telemetry data analysis to Decision Trees, from Bayesian methods to dealing with irate study directors, and now have a list of over 50 affiliates on our e-mail distribution list.
The PSI Pre-clinical Special Interest Group have a series of regular FREE webinars dealing with statistical topics faced in pre-clinical and related fields. The presentations will run for an hour, with approximately 45 min presentation and a Q&A session in the remaining time. See section below for details of this year’s webinars.
The PSI Pre-Clinical Special Interest Group seminars for 2021 are as follows:
Date | Title | Presenter | Slides/Video on Demand |
16 Mar | Beyond the looking glass – Interpreting animal welfare & behaviour by monitoring & assessing mice activity data | Eloisa Brook, Joanna Moore, George Birbeck. GSK | VoD |
29 Jun | Update from the Carcinogenicity working group | Steve Bailey. Pfizer | |
12 Oct | Therioepistomology | Dr Brianna Gaskill. Novartis |
|
For all previous webinars click here.
We are already planning for when we are able to hold face-to-face workshops again. Watch this space.
Join our mailing list by e-mailing this address with brief details of the field(s) you are working in.
